Wiseguyreports.Com Adds “Glucosamine -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021” To Its Research Database
Glucosamine Market research report analyzes the market by Type and Application at global level and for each of the geographic regions – North America, Europe, China, Asia-Pacific, and Rest of World. The Glucosamine market is segmented by Type into D-Glucosamine and N-Acetyl-Glucosamine; and by Application into Nutraceutical/Pharmaceutical, Feed Additives, and Food Ingredients. Global market by Volume in Metric Tons and Value in US$ is also included. Business profiles of 45 major companies are discussed in the report. Glucosamine market size serves as a guide to Glucosamine industry covering more than 450 companies that are engaged in Glucosamine R&D, processing, production, and distribution. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Compilation of Worldwide Patents and Research related to Glucosamine market is also provided. Estimations and predictions are graphically illustrated by 162 exclusive exhibits for all geographic regions.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30793-glucosamine-market-research-report
Glucosamine is a material that naturally occurs in the joints of the body. It is synthesized by the body from glucose (sugar) and glutamine. Glucosamine helps in making and repairing cartilage in the body. As humans grow old, the ability of the body to produce Glucosamine from glucose and glutamine also declines due to a decrease in the enzyme that aids production of Glucosamine. When Glucosamine Sulfate is not available in sufficient quantities, there is a degeneration of the cartilage. Glucosamine supplements could restore the Glucosamine levels in the body and also repair joints that are destroyed by osteoarthritis or other wounds. Global Glucosamine market is projected to increase at a CAGR of 17% from 2005 through 2020. Glucosamine based products were classified as nutraceuticals in most countries worldwide. But now a number of countries (especially Europe) are permitting glucosamine products to be registered as pharmaceuticals. Products sold as drugs need to be approved by national medicines agencies, whereas nutraceuticals in general are governed by much less demanding food regulations. As a result of the US anti-dumping action against shrimp shells from India and the EU ban on seafood imports from China, there was a steep rise in the price of Glucosamine. But since the uplift of the ban price of glucosamine has more or less stabilized. Change in the status of Glucosamine from drug to food has led to the market being opened up. Since its entrance on the food market, glucosamine has tripled in sales. The recommended dose of glucosamine is 1,500mg. Putting that level into food may cause an issue, due to its taste and also the expense. The introduction of combination products such as Vitabiotics’ Jointace [supplement] with collagen, glucosamine and chondroitin are undercutting sales for single glucosamine dietary supplements on the market. Glucosamine is traditionally sourced from shellfish, but one of the interesting areas in this field is the launch of vegetarian versions. Clearly, this opens up the supplement to a wider target market, and in addition prices are relatively stable compared to shellfish.
Report by Chapter
I. Scope and Methodology: This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.
II. Report Synopsis: Synopsis of the report summarizes the global market, by Glucosamine Type and Application. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values in US$ and Metric Tons from 2005 through 2020 for each geographic region including the US, Canada, UK, Germany, Spain, Czech Republic, Russia, China, Japan, India, Australia, South Korea, Israel, South Africa and Brazil.
III. Market Dynamics: Market Dynamics chapter provides information on global markets for Glucosamine. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Type and Application; brief business profiles of major global Glucosamine producers and Glucosamine product manufacturers; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.
IV. Product/Technology Research: This chapter gives an insight into Glucosamine market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Information regarding Glucosamine based drugs is also provided.
V. Corporate Directory: This chapter provides a global region-wise list of more than 240 companies, CROs and academic institutions that offer Glucosamine as raw material and products and/or services.
VI. Patents Information: This chapter provides a compilation of worldwide patents related to glucosamine products/services/technologies.
Company Insight Profiles List
A & Z Food Additives Co., Ltd. (China)
Bayir Chemicals (India)
Bioiberica SA (Spain)
Cargill, Inc. (USA)
Coastal Laboratories (India)
Fraken Biochem Co., Ltd. (China)
Hygieia Health Co., Ltd (Hong Kong)
JFC Technologies (USA)
Kraeber GmbH & Co. (Germany)
Lytone Enterprise, Inc. (Taiwan)
Norwegian Chitosan AS (Norway)
Pacific Rainbow International, Inc. (USA)
Pharmed Medicare (India)
Pharmline, Inc. (USA)
Sai Gluco Pharma (India)
Shandong Rongcheng Luyang Chemical Co., Ltd. (China)
Shandong Yibao Biologics Co., Ltd. (China)
Shreeji Pharma International (India)
Sinochem Qingdao Co., Ltd. (China)
Sinoway International (Jiangsu) Co., Ltd. (China)
TSI Health Sciences (USA)
Wanbury Ltd. (India)
Wellable Group Marine Biological & Chemical Co., Ltd. (China)
Yaizu Suisankagaku Industry Co., Ltd. (Japan)
Zhejiang Aoxing Biotechnology Co., Ltd. (China)
Zhejiang Candorly Pharmaceutical Co., Ltd. (China)
Zhejiang Medicines & Health Products I/E Co., Ltd. (ZMC) (China)
Why Buy This Report?
This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –
- Identify Market Opportunities
- Review and Analyze Global and Regional Markets
- Gauge Market Potential for your Products
- Identify Competition
- Use Market Research for exploring new areas
- Acquire Meaningful Guidelines for Strategic Planning
- Gear up for Market Entry
- Get Actionable Information
Analytics and data presented in each report pertain to several parameters such as –
- Global and Regional Market Sizes, Market Shares, Market Trends
- Product (Global and Regional) Market Sizes, Market Shares, Market Trends
- Technology Trends
- Corporate Intelligence
- Key Companies By Sales, Brands, Products
- Other Strategic Business Affecting Data
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK)